FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Massimo Morfini

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Italy

Phenomena

Metabolic Clearance Rate

Procedures

Co-author Network

Publications

TOP 3
Elena Santagostino; Annarita Tagliaferri; Alfonso Iorio; Maria Messina; Massimo Morfini
Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course - the Kogeniale project.
Silvia Linari; Daniela Melchiorre; G Montorzi; D Bartolozzi; M Benelli; M Borderi; Massimo Morfini
Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients.
Christian Carulli; Roberto Civinini; Fabrizio Matassi; Massimo Morfini; Massimiliano Tani; Massimo Innocenti
Intra-articular injections of hyaluronic acid induce positive clinical effects in knees of patients affected by haemophilic arthropathy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Massimo Morfini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elena Santagostino; Annarita Tagliaferri; Alfonso Iorio; Maria Messina; Massimo Morfini
Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course - the Kogeniale project.
Blood transfusion = Trasfusione del sangue 2013;11(2):272-80.
2013: Silvia Linari; Daniela Melchiorre; G Montorzi; D Bartolozzi; M Benelli; M Borderi; Massimo Morfini
Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients.
Haemophilia : the official journal of the World Federation of Hemophilia 2013;19(1):126-33.
2013: Christian Carulli; Roberto Civinini; Fabrizio Matassi; Massimo Morfini; Massimiliano Tani; Massimo Innocenti
Intra-articular injections of hyaluronic acid induce positive clinical effects in knees of patients affected by haemophilic arthropathy.
The Knee 2013;20(1):36-9.
2012: Elena Santagostino; Andreas Tiede; Christine Voigt; Iris Jacobs; Robert Klamroth; Claude Negrier; Ingrid Pabinger-Fasching; Massimo Morfini
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients.
Blood 2012;120(12):2405-11.
2012: Daniela Melchiorre; Anna Franca Milia; Massimo Morfini; Eloisa Romano; Gemma Benelli; Christian Carulli; Claudia Ceccarelli; Roberto Civinini; Serena Guiducci; Massimo Innocenti; Silvia Linari; Mirko Manetti; Marco Matucci-Cerinic; Lidia Ibba-Manneschi
RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology.
The Journal of rheumatology 2012;39(8):1678-86.
2012: C Carulli; R Civinini; Silvia Linari; C Martini; Massimo Morfini; M Tani; M Innocenti
Viscosupplementation in haemophilic arthropathy: a long-term follow-up study.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(3):e210-4.
2011: Massimo Morfini; J Bjerre
Pharmacokinetics and safety of a 270 mcg kg-1 dose of room temperature stable recombinant activated factor VII in patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(6):860-6.
2011: Augusto B Federici; Alfonso Iorio; Luciano Baronciani; Paolo Bucciarelli; Maria T Canciani; Giancarlo Castaman; Maria G Mazzucconi; Massimo Morfini; Emily Oliovecchio; Angiola Rocino; Mario Schiavoni; Pier M Mannucci
Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
Seminars in thrombosis and hemostasis 2011;37(5):511-21.
2011: Daniela Melchiorre; Silvia Linari; M Innocenti; I Biscoglio; M Toigo; M M Cerinic; Massimo Morfini
Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(1):112-7.
2009: Elena Santagostino; Massimo Morfini; G K-H Auerswald; G M Benson; S Z Salek; T Lambert; P Salaj; V Jimenez-Yuste; R C R Ljung
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(5):983-9.
2008: E Carlos Rodriguez-Merchan; U Hedner; L Heijnen; Victor Jimenez-Yuste; C A Lee; Massimo Morfini; F Querol; G Roosendaal; Elena Santagostino; L P Solimeno
Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 6():68-81.
2008: Massimo Morfini; P Laguna; C Leissinger
Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(4):873-5.
2008: Maurizio Margaglione; Giancarlo Castaman; Massimo Morfini; Angiola Rocino; Elena Santagostino; Giuseppe Tagariello; Anna Rita Tagliaferri; Ezio Zanon; Maria Patrizia Bicocchi; Giuseppe Castaldo; Flora Peyvandi; Rosa Santacroce; Francesca Torricelli; Elvira Grandone; Pier Mannuccio Mannucci
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype.
Haematologica 2008;93(5):722-8.
2007: Massimo Morfini; S Haya; Giuseppe Tagariello; Hartmut Pollmann; M Quintana; Berthold Siegmund; N Stieltjes; G Dolan; J Tusell
European study on orthopaedic status of haemophilia patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(5):606-12.
2007: Massimo Morfini; Günter Auerswald; R A Kobelt; G F Rivolta; J Rodriguez-Martorell; FA Scaraggi; Carme Altisent; J Blatny; A Borel-Derlon; V Rossi
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(5):502-7.
2007: M Innocenti; R Civinini; C Carulli; M Villano; Silvia Linari; Massimo Morfini
A modular total knee arthroplasty in haemophilic arthropathy.
The Knee 2007;14(4):264-8.
2007: Augusto B Federici; Giancarlo Castaman; Massimo Franchini; Massimo Morfini; Ezio Zanon; Antonio Coppola; Annarita Tagliaferri; Elio Boeri; Maria Gabriella Mazzucconi; Gina Rossetti; Pier Mannuccio Mannucci
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.
Haematologica 2007;92(7):944-51.
2007: Jorge Di Paola; M P Smith; R Klamroth; P M Mannucci; C Kollmer; J Feingold; C Kessler; Hartmut Pollmann; Massimo Morfini; C Udata; Chantal Rothschild; Cedric Hermans; R Janco
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(2):124-30.
2006: Massimo Franchini; D Girelli; O Olivieri; Giancarlo Castaman; Giuseppe Lippi; G Poli; G L Salvagno; Giuseppe Tagariello; Annachiara Giuffrida; Marzia De Gironcoli; Massimo Morfini; E Berntorp; Giorgio Gandini
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(4):448-51.
2006: M Lee; Massimo Morfini; Claude Negrier; Valérie Chamouard
The pharmacokinetics of coagulation factors.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 3():1-7.
2006: Elena Santagostino; Maria Elisa Mancuso; Massimo Morfini; Mario Schiavoni; Annarita Tagliaferri; Giovanni Barillari; Pier Mannuccio Mannucci
Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy.
Haematologica 2006;91(5):634-9.
2006: Sandro Cinotti; E Paladino; Massimo Morfini
Accuracy of FVIII: C assay by one-stage method can be improved using hemophilic plasma as diluent.
Journal of thrombosis and haemostasis : JTH 2006;4(4):828-33.
2005: P Tonelli; D Mannelli; L Brancato; Sandro Cinotti; Massimo Morfini
Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration.
Minerva stomatologica 2005;54(1-2):23-34.
2004: Alessandro Gringeri; Annarita Tagliaferri; Giuseppe Tagariello; Massimo Morfini; Elena Santagostino; Piermannuccio Mannucci
Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII.
British journal of haematology 2004;126(3):398-404.
2004: Ana Villar; S Aronis; Massimo Morfini; Elena Santagostino; Günter Auerswald; H F Thomsen; E Erhardtsen; P L F Giangrande
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(4):352-9.
2004: Man-Chiu Poon; Roseline d'Oiron; M Von Depka; K Khair; Claude Négrier; A Karafoulidou; A Huth-Kuehne; Massimo Morfini
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1096-103.
2004: A Srámek; Paolo Bucciarelli; Augusto B Federici; Pier M Mannucci; V De Rosa; Giancarlo Castaman; Massimo Morfini; Maria Gabriella Mazzucconi; Angiola Rocino; Mario Schiavoni; FA Scaraggi; Johan H C Reiber; Frits R Rosendaal
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.
Circulation 2004;109(6):740-4.
2003: Katalin Váradi; Claude Negrier; E Berntorp; Jan Astermark; Jean Claude Bordet; Massimo Morfini; Silvia Linari; Hans Peter Schwarz; Peter L Turecek
Monitoring the bioavailability of FEIBA with a thrombin generation assay.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2374-80.
2003: Massimo Morfini; Sandro Cinotti; A Bellatreccia; E Paladino; Alessandro Gringeri; P M Mannucci
A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standards.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2283-9.
2003: Erik Berntorp; Jan Astermark; Sven Björkman; Victor S Blanchette; K Fischer; P L F Giangrande; Alessandro Gringeri; Rolf Ljung; Marilyn J Manco-Johnson; Massimo Morfini; Ray F Kilcoyne; P Petrini; E Carlos Rodriguez-Merchan; W Schramm; Amy D Shapiro; H Marijke van den Berg; C Hart
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9 Suppl 1():1-4.
2003: Marco Matucci Cerinic; Gabriele Valentini; GG Sorano; S D'Angelo; Giovanna Cuomo; Lara Fenu; Sergio Generini; Sandro Cinotti; Massimo Morfini; Alberto Pignone; Serena Guiducci; Angela Del Rosso; Reni Kalfin; D Das; Francesco Marongiu
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
Seminars in arthritis and rheumatism 2003;32(5):285-95.
2003: Christopher A Ludlam; Mark P Smith; Massimo Morfini; Alessandro Gringeri; Elena Santagostino; Geoffrey F Savidge
A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation.
British journal of haematology 2003;120(5):808-13.
2003: Peter L Turecek; Katalin Váradi; B Keil; Claude Negrier; E Berntorp; Jan Astermark; Jean Claude Bordet; Massimo Morfini; Silvia Linari; Hans Peter Schwarz
Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.
Pathophysiology of haemostasis and thrombosis 2003;33(1):16-22.
2002: Sabrina Frusconi; Ilaria Passerini; Francesca Girolami; Maddalena Masieri; Silvia Linari; Giovanni Longo; Massimo Morfini; Francesca Torricelli
Identification of seven novel mutations of F8C by DHPLC.
Human mutation 2002;20(3):231-2.
2002: Cedric Hermans; Dale Owens; Giovanni Longo; Massimo Morfini; Christine A Lee
Single-dose pharmacokinetics of porcine factor VIII (Hyate C).
Thrombosis and haemostasis 2002;87(2):352-3.
2002: Cedric Hermans; D Owens; P Lilley; G Longo; Massimo Morfini; Christine A Lee
Single-dose pharmacokinetics of porcine factor VIII (Hyate C).
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8 Suppl 1():33-8.
2001: Alberta Azzi; R De Santis; Massimo Morfini; Krystyna Zakrzewska; Roberto Musso; Elena Santagostino; Giancarlo Castaman
TT virus contaminates first-generation recombinant factor VIII concentrates.
Blood 2001;98(8):2571-3.
2001: Sergio Boncinelli; Massimo Marsili; P Lorenzi; Lea Paola Fabbri; S Pittino; M Filoni; F Bressan; E Sarti; Sandro Cinotti; Massimo Morfini
Haemostatic molecular markers in patients undergoing radical retropubic prostatectomy for prostate cancer and submitted to prophylaxis with unfractioned or low molecular weight heparin.
Minerva anestesiologica 2001;67(10):693-703.
2001: Elena Santagostino; Massimo Morfini; Angiola Rocino; Francesco Baudo; FA Scaraggi; Alessandro Gringeri
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Thrombosis and haemostasis 2001;86(4):954-8.
2001: Sabrina Trippoli; Monica Vaiani; Silvia Linari; Giovanni Longo; Massimo Morfini; Andrea Messori
Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia.
Haematologica 2001;86(7):722-8.
2001: M Berrettini; G Mariani; Mario Schiavoni; Angiola Rocino; T Di Paolantonio; G Longo; Massimo Morfini
Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.
Haematologica 2001;86(6):640-5.
1999: Francesco Baudo; TM Caimi; Rosaria Redaelli; Francesco de Cataldo; G Somaini; Gianfranco Rondinara; A Degasperi; Giorgio Bellati; Luca S Belli; G Ideo; Massimo Morfini; G Longo
Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5(4):276-7.
1999: Alberta Azzi; Massimo Morfini; P M Mannucci
The transfusion-associated transmission of parvovirus B19.
Transfusion medicine reviews 1999;13(3):194-204.
1998: E Pasqual Marsettin; Nicola Ciavarella; C Lobaccaro; A Ghirardini; M Puopolo; D Cultraro; Massimo Morfini; Angiola Rocino
Knowledge of HIV/AIDS and emotional adjustment in a cohort of men with haemophilia and HIV infection: final report.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(6):820-5.
1998: Sam Schulman; Roseline d'Oiron; Uri martinowitz; John Pasi; Marie-Elisabeth Briquel; Eveline P Mauser-Bunschoten; Massimo Morfini; B Ritchie; Jenny Goudemand; J Lloyd; J McPherson; Claude Négrier; Kathelijne Peerlinck; P Petrini; J Tusell
Experiences with continuous infusion of recombinant activated factor VII.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S97-101.
1998: F Tradati; Massimo Colombo; Pier M Mannucci; Maria Grazia Rumi; Cristina De Fazio; G Gamba; Nicola Ciavarella; Angiola Rocino; Massimo Morfini; A Scaraggi; Emanuela Taioli
A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.
Blood 1998;91(4):1173-7.
1997: M G Rumi; Elena Santagostino; Massimo Morfini; Alessandro Gringeri; Giuseppe Tagariello; A Chistolini; Patrizia Pontisso; A Tagger; Massimo Colombo; Pier M Mannucci
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.
Blood 1997;89(10):3529-33.
1997: Elena Santagostino; Pier M Mannucci; Alessandro Gringeri; Alberta Azzi; Massimo Morfini; Roberto Musso; R Santoro; Mario Schiavoni
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
Transfusion 1997;37(5):517-22.
1996: Massimo Morfini; A Messori; Giovanni Longo
Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7 Suppl 1():S11-4.
1994: Alessandro M Vannucchi; D Rafanelli; Giovanni Longo; Alberto Bosi; Stefano Guidi; Riccardo Saccardi; E Filimberti; S Cinotti; Alberto Grossi; Massimo Morfini
Early hemostatic alterations following bone marrow transplantation: a prospective study.
Haematologica 1994;79(6):519-25.
1994: N Schinaia; A M Ghirardini; M G Mazzucconi; Giuseppe Tagariello; Massimo Morfini; Flavia Chiarotti
Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite.
Thrombosis and haemostasis 1994;72(1):33-8.
1994: Giuseppe Ficarra; M Chiodo; Massimo Morfini; Giovanni Longo; A Orsi; S Piluso; D Rafanelli
Oral lesions among HIV-infected hemophiliacs. A study of 54 patients.
Haematologica 1994;79(2):148-53.
1994: Massimo Morfini; Pier M Mannucci; N Ciavarella; M Schiavoni; Alessandro Gringeri; D Rafanelli; E Di Bona; A Chistolini; A Tagliaferri; G Rodorigo
Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation.
Vox sanguinis 1994;67(2):178-82.
1993: Guglielmo Mariani; T Di Paolantonio; R Baklaya; Massimo Morfini; Pier M Mannucci
Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
Transfusion 1993;33(10):814-8.
1993: Massimo Morfini; P M Mannucci; P M Tenconi; Giovanni Longo; Maria Gabriella Mazzucconi; F Rodeghiero; N Ciavarella; V De Rosa; A Arter
Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease.
Thrombosis and haemostasis 1993;70(2):270-2.
1993: Massimo Morfini; Giovanni Longo; E Berntorp; S Cinotti; E Filimberti; A Messori; I M Nilsson; Pierluigi Rossi Ferrini
Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate.
Thrombosis research 1993;71(3):175-84.
1993: M Acquila; Daniela Caprino; M Pecorara; F Baudo; Massimo Morfini; Pier Giorgio Mori
Two novel mutations at 373 codon of FVIII gene detected by DGGE.
Thrombosis and haemostasis 1993;69(4):392-3.
1992: Massimo Morfini; Giovanni Longo; A Messori; M Lee; G White; P Mannucci
Pharmacokinetic properties of recombinant factor VIII compared with a monoclonally purified concentrate (Hemofil M). The Recombinate Study Group.
Thrombosis and haemostasis 1992;68(4):433-5.
1992: E Filimberti; S Cinotti; Maurizio Salvadori; M Amato; Giovanni Longo; M Nazzari; Massimo Morfini
Hemodialysis with defibrotide: effects on coagulation parameters.
The International journal of artificial organs 1992;15(10):590-4.
1992: Krystyna Zakrzewska; Alberta Azzi; G Patou; Massimo Morfini; D Rafanelli; J R Pattison
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction.
British journal of haematology 1992;81(3):407-12.
1992: Alberto Pignone; M Matucci-Cerinic; Massimo Morfini; A Lombardi; Pierluigi Rossi Ferrini; Mario Cagnoni
Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritis.
Journal of internal medicine 1992;231(6):617-9.
1992: A Messori; Massimo Morfini; M Blomback; S Cinotti; Giovanni Longo; K Schimpf; K Schumacher; A Novakova-Banet; U Delvos; H Kjellman
Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity.
Thrombosis research 1992;65(6):699-708.
1992: Pier M Mannucci; Alessandro Gringeri; R de Biasi; F Baudo; Massimo Morfini; N Ciavarella
Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Thrombosis and haemostasis 1992;67(3):310-3.
1992: Alberta Azzi; S Ciappi; K Zakvrzewska; Massimo Morfini; G Mariani; P M Mannucci
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates.
American journal of hematology 1992;39(3):228-30.
1992: T Di Paolantonio; Guglielmo Mariani; A Ghirardini; Alessandro Gringeri; Pier M Mannucci; L Mastrullo; R De Biasi; G Giustarini; Massimo Morfini; M Schiavoni
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate.
Journal of medical virology 1992;36(2):71-4.
1992: Massimo Morfini; G Longo; Pierluigi Rossi Ferrini; Alberta Azzi; C Zakrewska; S Ciappi; P Kolumban
Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus.
American journal of hematology 1992;39(2):149-50.
1991: Alessandro M Vannucchi; Giovanni Longo; Alberto Bosi; S Cinotti; E Filimberti; Stefano Guidi; Riccardo Saccardi; Massimo Morfini; E Boni; Pierluigi Rossi Ferrini
Early haemostatic modifications following cryopreserved graft infusion.
Bone marrow transplantation 1991;8(3):171-6.
1991: S Cinotti; Giovanni Longo; A Messori; Massimo Morfini; M Blomback; K Schimpf; K Schumacher; H Kjellman; A Novakova-Banet; U Delvos
Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: a multi-center study.
Thrombosis research 1991;61(4):385-93.
1991: Massimo Morfini; P M Mannucci; Giovanni Longo; S Cinotti; A Messori
Comparative evaluation of the pharmacokinetics of three monoclonal factor VIII concentrates.
Thrombosis research 1991;61(3):285-90.
1990: Marco Matucci-Cerinic; Torello Lotti; A Lombardi; Alberto Pignone; Florenzo Iannone; E Beneforti; S Cinotti; Massimo Morfini; M Caignoni
Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
International journal of dermatology 1990;29(9):644-8.
1990: D Rafanelli; Alberto Grossi; Alessandro M Vannucchi; S Cinotti; Massimo Morfini; Pierluigi Rossi Ferrini
The effect of picotamide on platelet function in patients with myeloproliferative disorders.
Thrombosis and haemostasis 1990;63(3):525-6.
1990: Pier M Mannucci; Massimo Morfini
Determination of pharmacokinetics of replacement factor VIII.
Seminars in hematology 1990;27(2 Suppl 2):8-10.
1990: L Casula; S Murru; M Pecorara; M S Ristaldi; Gabriella Restagno; G Mancuso; Massimo Morfini; R De Biasi; F Baudo; A Carbonara
Recurrent mutations and three novel rearrangements in the factor VIII gene of hemophilia A patients of Italian descent.
Blood 1990;75(3):662-70.
1989: Massimo Marsili; P Lorenzi; M Librenti; L Doni; C Benassai; E Martini; Lea Paola Fabbri; S Cinotti; Massimo Morfini; Sergio Boncinelli
Defibrotide in extracorporeal circulation on healthy rabbits.
The International journal of artificial organs 1989;12(12):749-54.
1989: Massimo Morfini; D Rafanelli; E Filimberti; S Cinotti; E Piazza; Giovanni Longo; Pierluigi Rossi Ferrini
Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates.
Thrombosis research 1989;56(2):169-78.
1989: Pier M Mannucci; Alessandro R Zanetti; Alessandro Gringeri; E Tanzi; Massimo Morfini; A Messori; M C Tirindelli; R de Biasi; N Ciavarella; M Colombo
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Archives of internal medicine 1989;149(6):1333-7.
1989: Giovanni Longo; A Messori; Massimo Morfini; F Baudo; N Ciavarella; S Cinotti; E Filimberti; G Giustarini; A C Molinari; Pierluigi Rossi Ferrini
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations.
American journal of hematology 1989;30(3):140-9.
1988: Pier M Mannucci; Alessandro Gringeri; Massimo Morfini; R De Biasi; M C Tirindelli; Giacomo Tamponi; F Baudo; V Carnelli; N Ciavarella; M Colombo
Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs.
American journal of hematology 1988;29(4):211-4.
1988: O Bartolomei Corsi; Alberta Azzi; Massimo Morfini; Rosa Fanci; Pierluigi Rossi Ferrini
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates.
Journal of medical virology 1988;25(2):165-70.
1988: M Amato; Maurizio Salvadori; Franco Bergesio; A Messeri; E Filimberti; Massimo Morfini
Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
The International journal of artificial organs 1988;11(3):175-80.
1988: A Messori; Giovanni Longo; Massimo Morfini; S Cinotti; E Filimberti; G Giustarini; Pierluigi Rossi Ferrini
Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs.
European journal of clinical pharmacology 1988;35(6):663-8.
1987: A Messori; Giovanni Longo; M Matucci; Massimo Morfini; P L Ferrini
Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.
Clinical pharmacokinetics 1987;13(6):365-80.
1987: Giovanni Longo; S Cinotti; E Filimberti; G Giustarini; A Messori; Massimo Morfini; Pierluigi Rossi Ferrini
Single-dose pharmacokinetics of factor IX evaluated by model-independent methods.
European journal of haematology 1987;39(5):426-33.
1987: M Pecorara; L Casarino; Pier Giorgio Mori; Massimo Morfini; G Mancuso; A M Scrivano; Enzo Boeri; A C Molinari; R De Biasi; N Ciavarella
Hemophilia A: carrier detection and prenatal diagnosis by DNA analysis.
Blood 1987;70(2):531-5.
1986: Alessandro R Zanetti; Pier M Mannucci; E Tanzi; G A Moroni; M De Paschale; Massimo Morfini; V Carnelli; M C Tirindelli; R De Biasi; N Ciavarella
Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patients.
American journal of hematology 1986;23(4):339-45.
1986: Alfredo Zuppiroli; franco cecchi; Mauro Ciaccheri; G Italiani; Alberto Dolara; Giovanni Longo; M Matucci; Massimo Morfini; D Rafanelli
Platelet function and coagulation studies in patients with mitral valve prolapse.
Clinical cardiology 1986;9(10):487-92.
1986: Massimo Morfini; A Messori; Giovanni Longo; S Cinotti; M Matucci; Pierluigi Rossi Ferrini
Half-life and in-vivo recovery of heated factor VIII concentrates.
Lancet 1986;2(8506):571-2.
1986: S Ruffo; A Messori; Giovanni Longo; M Matucci; Massimo Morfini; Pierluigi Rossi Ferrini
A microcomputer program for individualizing factor VIII dosage in hemophilia patients undergoing major surgery.
Computer methods and programs in biomedicine 1986;23(1):37-46.
1986: Giovanni Longo; M Matucci; A Messori; Massimo Morfini; Pierluigi Rossi Ferrini
Pharmacokinetics of a new heat-treated concentrate of factor VIII estimated by model-independent methods.
Thrombosis research 1986;42(4):471-6.
1986: A Grossi; Alessandro M Vannucchi; P Casprini; Massimo Morfini; P R Ferrini
Effects of high-dose intravenous gammaglobulin on kinetic parameters of 51Cr-labelled platelets in chronic ITP.
Haematologica 1986;71(2):123-7.
1986: R Biagiotti; M G Giudizi; Fabio Almerigogna; M Mazzetti; A Alessi; Gianfranco Del Prete; D Rafanelli; M Fiorilli; Massimo Morfini; Sergio Romagnani
Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
Clinical and experimental immunology 1986;63(2):354-8.
1986: M G Giudizi; R Biagiotti; Fabio Almerigogna; M Mazzetti; A Alessi; G Massai; G Longo; G Scano; Massimo Morfini; Sergio Romagnani
HTLV-III seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes.
Scandinavian journal of haematology 1986;36(2):198-202.
1985: Massimo Morfini; T H Grasela; Giovanni Longo; M Matucci; A Messori; S Vannini; Pierluigi Rossi Ferrini
Comparison of two pharmacokinetic techniques for individualizing factor VIII dosage in haemophilia patients.
Haematologica 1985;70(5):454-6.
1985: Massimo Morfini; Alessandro M Vannucchi; Alberto Grossi; S Cinotti; D Rafanelli; Pierluigi Rossi Ferrini
Direct evidence that high dose intravenous gammaglobulin blocks splenic and hepatic sequestration of 51Cr-labeled platelets in ITP.
Thrombosis and haemostasis 1985;54(2):554.
1985: S Ruffo; A Messori; T H Grasela; Giovanni Longo; G Donati-Cori; M Matucci; Massimo Morfini; E Tendi
A calculator program for clinical application of the Bayesian method of predicting plasma drug levels.
Computer programs in biomedicine 1985;19(2-3):167-77.
1985: M Matucci; A Messori; G Donati-Cori; Giovanni Longo; S Vannini; Massimo Morfini; E Tendi; Pierluigi Rossi Ferrini
Kinetic evaluation of four Factor VIII concentrates by model-independent methods.
Scandinavian journal of haematology 1985;34(1):22-8.
1984: Massimo Morfini; Giovanni Longo; M Matucci; S Vannini; A Messori; E Filimberti; M Duminuco; G Avanzi; Pierluigi Rossi Ferrini
Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
La Ricerca in clinica e in laboratorio 1984;14(4):681-91.
1984: Giovanni Longo; M Matucci; Massimo Morfini; S Vannini; A Messori
A calculator program for individualizing factor VIII dosage.
Drug intelligence & clinical pharmacy 1984;18(9):726-30.
1984: S Ruffo; M Matucci; Giovanni Longo; Massimo Morfini; S Vannini; A Messori; G Donati-Cori; E Tendi; T Valenza; Gaetano Zaccara
A weighted least-squares approach for fitting to kinetic models the plasma concentration data of phenytoin and Factor VIII.
Il Farmaco; edizione pratica 1984;39(7):211-21.
1984: A Messori; Giovanni Longo; Massimo Morfini; G Donati-Cori; M Matucci; S Ruffo; E Tendi; S Vannini
Individualization of Factor VIII dosage.
Journal of clinical and hospital pharmacy 1984;9(2):95-103.
1984: Giovanni Longo; franco cecchi; A Grossi; M Matucci; D Rafanelli; Alessandro M Vannucchi; P Casprini; S Vannini; Massimo Morfini; Alberto Dolara
Coagulation and platelet function in hypertrophic cardiomyopathy.
Thrombosis and haemostasis 1984;51(2):299.
1983: A Passaleva; G Massai; Massimo Morfini; G Longo; P L Rossi Ferrini; M Ricci
Circulating immune complexes in haemophilia and von Willebrand's disease.
Scandinavian journal of haematology 1983;31(5):466-74.
1983: M Matucci; Giovanni Longo; Massimo Morfini; S Vannini; A Messori; G Donati-Cori; E Tendi
Pharmacokinetics of factor VIII:C. Appropriateness of the one-compartment model for estimating clearance.
Il Farmaco; edizione pratica 1983;38(8):306-11.
1983: A Checcucci; G Benelli; M Duminuco; M L Gaetani; P Paoletti; S Vannini; Massimo Morfini
Reliability of microwave heating for hemoderivative thawing.
The Journal of microwave power 1983;18(2):163-8.
1982: F Cordopatri; Sergio Boncinelli; Massimo Marsili; P Lorenzi; Lea Paola Fabbri; P Paci; Maurizio Salvadori; Massimo Morfini; S Cinotti; P Casparini
Effects of charcoal hemoperfusion with prostacyclin on the coagulation-fibrinolysis system and platelets of patients with fulminant hepatic failure--preliminary observations.
The International journal of artificial organs 1982;5(4):243-7.